Candidate Markers That Associate with Chemotherapy Resistance in Breast Cancer through the Study on Taxotere-Induced Damage to Tumor Microenvironment and Gene Expression Profiling of Carcinoma-Associated Fibroblasts (CAFs)

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Rong, Guohua ^a   Kang, Hua ^a   Wang, Yajun ^a   Hai, Tao ^a   Sun, Haichen ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR7; CXCL2 CHEMOKINE; DOCETAXEL; FIBROBLAST GROWTH FACTOR 1; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; TUMOR MARKER;

ARTICLE; BREAST CANCER; CANCER RESISTANCE; CARCINOMA ASSOCIATED FIBROBLAST; CELL ADHESION; CELL FUNCTION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CXCL2 GENE; CXCR7 GENE; DISEASE ASSOCIATION; DISEASE MARKER; DOWN REGULATION; DRUG RESPONSE; FIBROBLAST; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERLEUKIN 8 GENE; MICROARRAY ANALYSIS; MMP1 GENE; MOLECULAR DYNAMICS; ONCOGENE; PREDICTION; PROTEIN DETERMINATION; PROTEIN FUNCTION; RARRES1 GENE; TUMOR GENE; TUMOR INVASION; TUMOR MICROENVIRONMENT; UPREGULATION;

ANTINEOPLASTIC AGENTS; BREAST; BREAST NEOPLASMS; CARCINOMA; CELL ADHESION; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; DRUG RESISTANCE, NEOPLASM; FEMALE; FIBROBLASTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; TAXOIDS; TRANSCRIPTOME; TUMOR MICROENVIRONMENT;

EID: 84881329436     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070960     Document Type: Article

References (45)

1. Siegel R, Naishadham D, Jemal A, (2012) Cancer statistics, 2012. CA: a cancer journal for clinicians 62: 10-29.
2. CTSU RI, (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365: 1687-1717.
3. Andre F, Berrada N, Desmedt C, (2010) Implication of tumor microenvironment in the resistance to chemotherapy in breast cancer patients. Current opinion in oncology 22: 547-551.
4. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, et al. (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121: 335-348.
5. Polyak K, Hahn WC, (2006) Roots and stems: stem cells in cancer. Nature medicine 12: 296-300.
6. Farmer P, Bonnefoi H, Anderle P, Cameron D, Wirapati P, et al. (2009) A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer. Nature medicine 15: 68-74.
7. Netti PA, Berk DA, Swartz MA, Grodzinsky AJ, Jain RK, (2000) Role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer research 60: 2497-2503.
8. Loeffler M, Kruger J, Niethammer AG, Reisfeld RA, (2006) Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake. Journal of Clinical Investigation 116: 1955-1962.
9. Artacho-Cordón A, Artacho-Cordón F, Ríos-Arrabal S, Calvente I, Núñez MI, (2012) Tumor microenvironment and breast cancer progression: A complex scenario. Cancer Biology & Therapy 13: 14-24.
10. Kalluri R, Zeisberg M, (2006) Fibroblasts in cancer. Nature Reviews Cancer 6: 392-401.
11. Ostman A, Augsten M, (2009) Cancer-associated fibroblasts and tumor growth-bystanders turning into key players. Current opinion in genetics & development 19: 67-73.
12. Ronnov-Jessen L, Celis JE, Van Deurs B, Petersen OW, (1992) A fibroblast-associated antigen: characterization in fibroblasts and immunoreactivity in smooth muscle differentiated stromal cells. Journal of Histochemistry & Cytochemistry 40: 475-486.
13. Petersen OW, Nielsen HL, Gudjonsson T, Villadsen R, Rank F, et al. (2003) Epithelial to mesenchymal transition in human breast cancer can provide a nonmalignant stroma. The American journal of pathology 162: 391-402.
14. Direkze NC, Hodivala-Dilke K, Jeffery R, Hunt T, Poulsom R, et al. (2004) Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer research 64: 8492-8495.
15. Jotzu C, Alt E, Welte G, Li J, Hennessy BT, et al. (2010) Adipose tissue-derived stem cells differentiate into carcinoma-associated fibroblast-like cells under the influence of tumor-derived factors. Cellular Oncology 33: 61-79.
16. Moskovits N, Kalinkovich A, Bar J, Lapidot T, Oren M, (2006) p53 Attenuates cancer cell migration and invasion through repression of SDF-1/CXCL12 expression in stromal fibroblasts. Cancer research 66: 10671-10676.
17. Trimis G, Chatzistamou I, Politi K, Kiaris H, Papavassiliou AG, (2008) Expression of p21waf1/Cip1 in stromal fibroblasts of primary breast tumors. Human molecular genetics 17: 3596-3600.
18. Trimboli AJ, Cantemir-Stone CZ, Li F, Wallace JA, Merchant A, et al. (2009) Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature 461: 1084-1091.
19. Trimmer C, Sotgia F, Whitaker-Menezes D, Balliet RM, Eaton G, et al. (2011) Caveolin-1 and mitochondrial SOD2 (MnSOD) function as tumor suppressors in the stromal microenvironment: a new genetically tractable model for human cancer associated fibroblasts. Cancer Biology & Therapy 11: 383-394.
20. Aboussekhra A, (2011) Role of cancer-associated fibroblasts in breast cancer development and prognosis. Int J Dev Biol 55: 841-849.
21. Perez EA, (2009) Impact, mechanisms, and novel chemotherapy strategies for overcoming resistance to anthracyclines and taxanes in metastatic breast cancer. Breast cancer research and treatment 114: 195-201.
22. Untch M, Von Minckwitz G, (2009) Advances in neoadjuvant (primary) systemic therapy with cytotoxic agents. Breast Cancer Research 11: 203.
23. Wolff AC, Berry D, Carey LA, Colleoni M, Dowsett M, et al. (2008) Research issues affecting preoperative systemic therapy for operable breast cancer. Journal of Clinical Oncology 26: 806-813.
24. Han W, Woo JH, Jeon YK, Yang SJ, Cho J, et al. (2011) 17p12 deletion in breast cancer predicts resistance to neoadjuvant chemotherapy. Experimental and Therapeutic Medicine 2: 799-804.
25. Hilton J, Weberpals J, Lorimer I, Amin S, Islam S, et al. (2012) BRCA1 protein levels and PIK3CA mutations as predictive biomarkers for response to neoadjuvant chemotherapy in locally advanced breast cancer: An exploratory analysis. Oncology Letters 4: 141-145.
26. Sonnenberg M, Van Der Kuip H, Haubeis S, Fritz P, Schroth W, et al. (2008) Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breast. BMC cancer 8: 364.
27. Vandercappellen J, Van Damme J, Struyf S, (2008) The role of CXC chemokines and their receptors in cancer. Cancer letters 267: 226-244.
28. Doll D, Keller L, Maak M, Boulesteix AL, Siewert JR, et al. (2010) Differential expression of the chemokines GRO-2, GRO-3, and interleukin-8 in colon cancer and their impact on metastatic disease and survival. International journal of colorectal disease 25: 573-581.
29. Burgess M, Cheung C, Chambers L, Ravindranath K, Minhas G, et al. (2012) CCL2 and CXCL2 enhance survival of primary chronic lymphocytic leukemia cells in vitro. Leukemia & lymphoma 53: 1988-1998.
30. Burgess M, Cheung C, Chambers L, Ravindranath K, Minhas G, et al. (2010) CCL2 and CXCL2 enhance survival of primary chronic lymphocytic leukemia cells in vitro. Leukemia & lymphoma 29: 285-293.
31. Hu C, Wang J, Xu Y, Li X, Chen H, et al. (2013) Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: A meta-analysis. Gene 1119: 1644-1647.
32. Li X, Tai HH, (2012) Increased Expression of Matrix Metalloproteinases Mediates Thromboxane A2-Induced Invasion in Lung Cancer Cells. Current Cancer Drug Targets 12: 703-715.
33. Roberti MP, Arriaga JM, Bianchini M, Quinta HR, Bravo AI, et al. (2012) Protein expression changes during human triple negative breast cancer cell line progression to lymph node metastasis in a xenografted model in nude mice. Cancer Biology & Therapy 13: 1123-1140.
34. Reis ST, Leite KRM, Piovesan LF, Pontes-Junior J, Viana NI, et al. (2012) Increased expression of MMP-9 and IL-8 are correlated with poor prognosis of Bladder Cancer. BMC urology 12: 18-23.
35. Wang Y, Xu RC, Zhang XL, Niu XL, Qu Y, et al. (2012) Interleukin-8 secretion by ovarian cancer cells increases anchorage-independent growth, proliferation, angiogenic potential, adhesion and invasion. Cytokine 59: 145-155.
36. Korantzis I, Kalogeras K, Papaxoinis G, Kotoula V, Koutras A, et al. (2012) Expression of Angiogenic Markers in the Peripheral Blood of Patients with Advanced Breast Cancer Treated with Weekly Docetaxel. Anticancer research 32: 4569-4580.
37. Snoussi K, Mahfoudh W, Bouaouina N, Fekih M, Khairi H, et al. (2010) Combined effects of IL-8 and CXCR2 gene polymorphisms on breast cancer susceptibility and aggressiveness. BMC cancer 10: 283.
38. Lee Y, Choi I, Ning Y, Kim N, Khatchadourian V, et al. (2012) Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasis. British journal of cancer 106: 1833-1841.
39. Marcinkowska E, Superat K, Wieogondlocha A, (2006) FGF-1 as a possible carrier for targeted drug delivery. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 16: 27-34.
40. Szlachcic A, Pala K, Zakrzewska M, Jakimowicz P, Wiedlocha A, et al. (2012) FGF1-gold nanoparticle conjugates targeting FGFR efficiently decrease cell viability upon NIR irradiation. International Journal of Nanomedicine 7: 5915-5927.
41. Jing C, El-Ghany MA, Beesley C, Foster CS, Rudland PS, et al. (2002) Tazarotene-induced gene 1 (TIG1) expression in prostate carcinomas and its relationship to tumorigenicity. Journal of the National Cancer Institute 94: 482-490.
42. Kwok WK, Pang JCS, Lo KW, Ng HK, (2009) Role of the RARRES1 gene in nasopharyngeal carcinoma. Cancer genetics and cytogenetics 194: 58-64.
43. Wu CC, Shyu RY, Chou JM, Jao SW, Chao PC, et al. (2006) RARRES1 expression is significantly related to tumour differentiation and staging in colorectal adenocarcinoma. European Journal of Cancer 42: 557-565.
44. Liberman J, Sartelet H, Flahaut M, Muhlethaler-Mottet A, Coulon A, et al. (2012) Involvement of the CXCR7/CXCR4/CXCL12 Axis in the Malignant Progression of Human Neuroblastoma. PloS one 7: e43665.
45. Hernandez L, Magalhaes MAO, Coniglio SJ, Condeelis JS, Segall JE, (2011) Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis. Breast Cancer Research 13: R128.